Review articles must distinguish clearly between established evidence, emerging hypotheses, and speculative opportunities
Among the GLP-1 RAs and a dual GLP-1/GIP RA, exenatide has the most developed pharmacokinetic model (9 of 30), 61,177184 followed by semaglutide (8 of 30), 68,162,182,185189 liraglutide and dulaglutide (each 5 of 30), 156,177,182,189194 and tirzepatide (3 of 30)
doi:10.1093/clinchem/41.10.1509 36
Alzheimers Association
Most of my viewers and listeners have been following my podcast for years
Learn More Learn More GET EMAIL ALERTS Sign up for our mailing list to receive updates, exclusive offers, and more!